AIDS Therapy

International HIV vaccine trial under way in Africa and the United States

Published in AIDS Weekly, July 28th, 2003

St. Louis University is leading an international vaccine trial to study a promising HIV prevention vaccine in humans. The trial is being conducted through the HIV Vaccine Trials Network (HVTN) of the U.S. National Institutes of Health.

This is the first HVTN trial to be conducted simultaneously in the U.S. and abroad, and it signifies a dedication to transcending borders in the fight against HIV. This vaccine has never been tested in humans.

"Scientists want to know more about this candidate vaccine because it seems to have the ability to make the immune system respond in ways that could help the body fight HIV," said Geoffrey Gorse, MD, from St....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2003-07-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry